Chemical Management, Science and Research

Three Keys to Recession Proofing the Chemical Industry Supply Chain

January 27, 2023

Three Keys to Recession
Most chemical companies are reporting strong revenue
growth, fueled by significant pricing increases; but they
also cite rising raw materials, energy, and logistics costs
as current concerns, combined with softening demand in
most segments.

Spotlight

AcelRx Pharmaceuticals, Inc

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company’s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A

OTHER WHITEPAPERS
news image

Using A Digital Twin to Enable Safe, Reliable and Efficient Design and Operation

whitePaper | July 15, 2021

Subsea engineering and production present some of the most complex engineering challenges in the energy industry. Deepwater, harsh offshore environments and complex operating conditions make design, installation and reliable operation even more challenging than onshore or platform-based systems. In this white paper we look at the role of engineering simulation across a wide range of aspects related to the full lifecycle of subsea equipment and facilities throughout the operating life.

Read More
news image

Petrochemical Processing

whitePaper | February 4, 2020

Outstanding process technology Together with the proven furnace technology Linde offers a separation process which is based on a unique sequence with front-end hydrogenation and open loop heat pump driven C2 splitter. These cornerstones of Linde’s technology have been developed during 60 years in cryogenic separation of ethylene from gas mixtures. The separation technology of Linde is superior to other concepts and has been applied to improve the performance even in plants of competitive technologies.

Read More
news image

Chemical Manufacture PROTECTING CRITICAL PROCESS CONTROL NETWORKS

whitePaper | December 27, 2019

chemical company, serves customers globally in over 90 countries. With over $30 billion in revenue, they provide coatings, paper and plastics products for agriculture, nutrition, electronics and many other industries. They operate a sophisticated set of process control systems to manage the quality and safety of their chemical plant operations.

Read More
news image

plasticfree to future-proof plastics

whitePaper | January 20, 2023

Plastics are shrouded in controversial debates. While manufacturers have been highlighting the benefits of plastics for decades, there are more and more stakeholders demanding a complete refuse, referring to the environmental problems associated with the use of plastic.

Read More
news image

Expanding the Capabilities of Modern SizeExclusion Chromatography with Advanced Particle and Column Hardware

whitePaper | July 22, 2022

Size-exclusion chromatography (SEC) is one of the most commonly used methods for measuring protein aggregation or protein self-association, because of its precision and ease of use.

Read More
news image

Sustainable Polymers

whitePaper | October 21, 2022

Products made from polymers are all around us – from safe and hygienic food and personal care packaging to clothing made of synthetic fibers that protect us from harmful UV rays.

Read More

Spotlight

AcelRx Pharmaceuticals, Inc

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company’s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A

Events